Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market Opportunity by 2030
UF Startup Kate Therapeutics, a gene therapy specialist, is being acquired by Novartis in a deal worth up to $1.1 billion. This acquisition aligns with Novartis’s efforts to deliver treatments for neuromuscular disorders and fits into the pharma’s strategy to expand its new modality pipeline, ensuring long-term business sustainability.
Kriya Announces Publication of Preclinical Data for Its Investigational AAV-FGF21 Gene Therapy Demonstrating Durable Reversal of Liver Fibrosis
UF Startup Kriya Therapeutics, a biopharmaceutical company developing gene therapies to address common diseases affecting millions of people around the world, announced the publication of preclinical data for its investigational AAV-FGF21 gene therapy.
Solid Biosciences To Present at the Jefferies London Healthcare Conference
Solid Biosciences Inc., a biotechnology company that acquired UF startup AavantiBio, announced that Bo Combo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will present at the Jefferies London Healthcare Conference on November 20.
NovaBone Secures FDA Clearance for Expanded Indications of Putty in Interbody Fusion Applications
UF Startup NovaBone Products announced that it has received FDA clearance for its bioactive synthetic bone graft, NovaBone Putty, which is now expandable for use in the intervertebral disc space.
Atsena Therapeutics and Nippon Shinyaku Enter Exclusive License Agreement for ATSN-101
Atsena Therapeutics Inc., a UF Startup, has entered into an exclusive license agreement with Nippon Shinyaku Co., Ltd. for the commercialization of ATSN-101 in the United States, and for its development and commercialization in Japan.
Innovative Molekule Air Purifiers Now Available at Crate & Barrel
UF startup Molekule announced that its air purifiers are now available for purchase online at Crate & Barrel, expanding consumer reach and accessibility.
Genascence Granted FDA Fast Track Designation for GNSC-001 in Patients With Osteoarthritis (OA) of the Knee
UF Startup Genascence Corporation announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) for GNSC-001, a potential first-in-class gene therapy for the treatment of patients with osteoarthritis (OA) of the knee.
Soilcea Modified Sweet Orange Receives Favorable Decision
UF Startup Soilcea’s modified sweet orange, which reportedly has resistance to HLB, has been determined by the U.S. Department of Agriculture Animal and Plant Health Inspection Service (USDA APHIS) to be neither a plant pest nor a plant that requires regulation under 7 CFR part 340.
RTI Surgical Completes Acquisition of Collagen Solutions
UF Startup RTI Surgical, a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine, announced it has successfully completed the acquisition of Collagen Solutions, a premier global supplier of engineered medical-grade collagen and xenograft tissue.
RTI Surgical Completes $15M Facility Expansion in Florida for Class III Medical Devices
UF Startup RTI Surgical, a contract development and manufacturing organization has announced the completion of a new $15 million, 5,000 sq-ft Class III medical device facility in Alachua, Florida, aiming to meet rising demand in the regenerative medicine sector.
